韩艳秋 - The Affiliated Hospital, Inner Mongolia Medical University

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 155 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Olverembatinib-Based Therapy in Patients with Philadelphia Chromosome-Positive Acute Leukemia: A Multi-Centre Retrospective Study from China

Mei Bao,Jian Huang, Huiying Qiu, Suning Chen, Shengli Xue,Xiaofei Yang,Zhenfang Liu,Chunyan Chen,Linhua Yang,Yanping Ma,Li Meng, Yanli Zhang,

Bloodno. Supplement 1 (2024): 4528-4528

引用0浏览0引用

Acalabrutinib in Chinese Patients with Relapsed/refractory Chronic Lymphocytic Leukemia: Primary Analysis from an Open-Label, Multicenter Phase 1/2 Trial

Shenmiao Yang,Haiwen Huang,Keshu Zhou,Xielan Zhao,Yanqiu Han,Lindong Li, Yujie Wang, Xiaofeng Liu,Jianyong Li

Annals of Hematologypp.1-12, (2024)

引用0浏览0WOS引用

A Multicenter Retrospective Comparison Between Systemic Mastocytosis with T(8;21) AML and KIT Mutant T(8;21) AML

Zhibo Zhang,Jia Yin,Guoli Lian,Xiebing Bao, Meng Hu,Zhenfang Liu,Yuan Yu,Ruihua Mi,Yabei Zuo,Pengcheng Shi,Weiyan Zheng,Qian Jiang,

Blood Advancesno. 4 (2024): 889-894

引用0浏览0WOS引用

CACA guidelines for holistic integrative management of adult acute myeloid leukemia

Hui Wei,Yingchang Mi,Ying Wang,Erlie Jiang,Jianda Hu,Xiaojing Yan,Yanqiu Han,Yongrong Lai,Yong You,Sujun Gao,Chunji Gao,Bing Xu,

Holistic Integrative Oncologyno. 1 (2024): 1-12

引用0浏览0引用

Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis

Xiaoshuai Zhang, Lu Yu,Li Zhou, Yanli Zhang, Huanling Zhu, Bingcheng Liu,Xin Du, Xiaodong Wang,Linhua Yang,Yanping Ma,Li Meng, Yanqing Zhang,

Bloodno. Supplement 1 (2024): 4529-4529

引用0浏览0引用

Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China

Mengyao Yuan,Li Zhou,Xin Du,Jianyu Weng,Linhua Yang,Yanping Ma, Shasha Zhao,Zhenfang Liu,Qin Wen,Qingxian Bai, Xianqi Feng,Yanqiu Han,

Bloodno. Supplement 1 (2024): 1767-1767

引用0浏览0引用

Acalabrutinib in Chinese Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 24-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial

Shenmiao Yang,Haiwen Huang,Keshu Zhou,Xielan Zhao,Yanqiu Han, Lindong Li, Yujie Wang, Xiaofeng Liu,Jianyong Li

Bloodno. Supplement 1 (2024): 6767-6767

引用0浏览0引用

Comparison of the Efficacy among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study

Xiaoshuai Zhang,Na Xu,Yunfan Yang,Hai Lin,Bingcheng Liu,Xin Du,Xiaoli Liu,Rong Liang,Chunyan Chen,Jian Huang,Huanling Zhu,Ling Pan,

CLINICAL LYMPHOMA MYELOMA & LEUKEMIAno. 6 (2024): e257-e266

引用0浏览0WOS引用

Accuracy of the Sysmex UF-5000 Analyzer for Urinary Tract Infection Screening and Pathogen Classification

Hua Wang, Fei-Fei Han,Jian-Xun Wen,Zhi Yan,Yan-Qiu Han,Zhi-De Hu,Wen-Qi Zheng

PLOS ONE（2023）

引用0浏览0WOS引用

PB2482: ROXADUSTAT SUPPRESSES ADIPOGENESIS IN HUMAN BMMSC AND PROMOTES EPO PRODUCTION VIA REGULATION OF HIF SIGNALING PATHWAYS

Jing Zhang,Hui-Juan Ren,LI-Xia Cao, Lan Yang,Qiu-Yu Chen,Yan-Qiu Han

HemaSphereno. S3 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

YanQiu Han(韩艳秋)

论文共 155 篇作者统计合作学者相似作者